Cartridges Market, Size, Share, Growth, and Industry Analysis, By Material Type (Glass and Plastic), By Size (1ml to 5ml, 5ml to 15ml and 15ml to 30ml), By Application (Diabetes and Others), Regional Forecast to 2034

Global Cartridges Market

The global cartridges market is expected to witness a CAGR of 7.1% between 2025-2034, driven by the rising demand for prefillable and ready-to-use drug delivery systems across chronic and acute therapeutic segments. Cartridges, typically used in pen injectors and autoinjectors, play a critical role in ensuring accurate dosing, sterility, and patient convenience. With the increasing prevalence of chronic diseases such as diabetes and the shift toward self-administration of biology, cartridges have emerged as an integral component of modern drug delivery. The market is characterized by advancements in material engineering, precision molding, and pharmaceutical-grade manufacturing, aligning with stringent regulatory requirements and evolving patient-centric healthcare models.

Demand by Material Type

By material type, the market is segmented into glass and plastic cartridges. Glass cartridges continue to dominate due to their superior chemical resistance, excellent barrier properties, and compatibility with a wide range of injectable drugs. Borosilicate glass, in particular, is preferred for insulin and biologic formulations owing to its stability and low extractables profile. However, plastic cartridges are gaining traction, especially in applications requiring lightweight design, enhanced break resistance, and cost efficiency. The development of high-performance cyclic olefin polymers (COP) and cyclic olefin copolymers (COC) is expanding the scope of plastic cartridges in advanced drug delivery systems. As pharmaceutical companies seek differentiation in device design and patient usability, plastic cartridges are expected to witness accelerated adoption in the coming years.

Demand by Size

Based on size, the cartridges market is categorized into 1ml to 5ml, 5ml to 15ml, and 15ml to 30ml. The 1ml to 5ml segment holds a significant share, primarily due to its widespread use in insulin pens and other subcutaneous injectable therapies. These compact cartridges are optimized for precise dosing and patient convenience, making them highly suitable for diabetes management and other chronic conditions. The 5ml to 15ml segment is gaining momentum with the growing use of biologics and specialty pharmaceuticals that require moderate-volume delivery. Meanwhile, the 15ml to 30ml segment is finding niche applications in specialized therapies and certain veterinary or hospital-based uses. As drug pipelines increasingly feature biologics and combination therapies, demand across varied cartridge sizes is expected to remain robust.

Demand by Application

In terms of application, diabetes represents the dominant segment in the global cartridges market. The rising global burden of diabetes, particularly in emerging economies, is fueling the demand for insulin delivery systems, including reusable and disposable pen injectors. The convenience, accuracy, and patient compliance associated with cartridge-based pen systems have made them a preferred choice over traditional vial-and-syringe methods. The "others" segment, encompassing hormonal therapies, fertility treatments, and biologic drugs, is also expanding rapidly. As more injectable drugs transition to self-administration formats, cartridges are poised to capture a larger share of the injectable drug delivery ecosystem.

Market Driver

A key driver of the global cartridges market is the rising prevalence of diabetes worldwide, coupled with the growing adoption of pen-based insulin delivery systems. As healthcare systems emphasize home-based care and improved patient adherence, cartridge-integrated injectors offer a compelling value proposition in terms of safety, accuracy, and convenience.

Market Restraint

One significant restraint is the stringent regulatory and quality compliance requirements associated with pharmaceutical packaging components. Manufacturing cartridges demands high capital investment in cleanroom facilities, advanced inspection systems, and validation processes, which can limit market entry and exert pricing pressure on smaller manufacturers.

Demand by Region

North America remains a leading market, supported by high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of self-injection devices. The presence of major pharmaceutical companies and stringent regulatory standards further drives demand for high-quality, compliant cartridge systems. Europe follows closely, with robust demand stemming from established pharmaceutical manufacturing hubs and strong emphasis on patient safety and device innovation. Countries such as Germany and Switzerland serve as key centers for glass and specialty packaging production.

Asia-Pacific is emerging as the fastest-growing region, propelled by a rapidly expanding diabetic population, increasing healthcare access, and rising pharmaceutical manufacturing capabilities. Countries such as China and India are witnessing growing investments in injectable drug production, boosting demand for both glass and plastic cartridges. Additionally, cost-competitive manufacturing and expanding export activities are strengthening the region's position in the global supply chain.

Key Manufacturers

The major players operating in the market include Stevanato group, Nipro corporation, Gerreshimer AG, West Pharmaceutical services Inc., Schott AG, Transcoject GmbH, Shandong Medicinal Glass Co ltd, Datwlyer Holding Inc, Aptar Group Inc, Sonata Rubber

Overall, the global cartridges market is positioned for steady expansion, supported by innovation in materials, rising chronic disease prevalence, and the ongoing transformation of injectable drug delivery toward patient-centric solutions.